Published Date: 27 Dec 2024
Promising single-agent efficacy with manageable safety may reshape initial treatment
Read Full News1.
Win for Perioperative Durvalumab in Muscle-Invasive Bladder Cancer
2.
investigating radiation oncology applications of artificial general intelligence.
3.
Delay of more than 42 days for breast cancer surgery raises death risk for certain subtypes, study finds
4.
In Biochemically Recurrent Nonmetastatic Prostate Cancer, Apalutamide Presents Its Argument.
5.
Colon cancer and exercise: Can physical activity reprogram genes?
1.
Tertiary Lymphoid Structures in Cancer: Advancing Therapeutic Implications
2.
Navigating the Stages of Thyroid Cancer: A Guide for Patients
3.
Respiratory Ramifications of Systemic Disease: A Comprehensive Review
4.
Advancing Cancer Treatment: Precision Pharmaceutical Care in Oncohematology
5.
Integrative Cancer Care: Nutrition, Social Work, Care Coordination, and Genetic Counseling
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
3.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
4.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
5.
Updates on the First Line Management of ALK+ NSCLC
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation